<div>
                                <figure class="article-image__container">
                                    
                                    
                                    
                                    <img src="https://imageproxy.pbkrs.com/https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2025/12/PTF-2601_web_main-1-430x241.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="430" height="241" original-src="https://imageproxy.pbkrs.com/https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2025/12/PTF-2601_web_main-1-430x241.jpg"/>
                                    
                                    <figcaption></figcaption>
                                </figure>
                            </div>
                                             
     
<p>As we head into the new year, now is the time to look back on the activity seen in the pharma space in 2025 and consider what it can tell us about the market’s development in 2026.</p>



<p>This month’s cover story look at the rise in deal value across 2025 compared to 2024, considering what fuelled M&amp;A this year and what 2026 may hold. </p><div>
<div id="div-gpt-ad-6065588-4"></div>
  
</div><div><div>
                   <div><h3>Go deeper with GlobalData</h3><ul><li><div><figure><img src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png" alt="ReportsLogo" original-src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png"/></figure></div><div><div>Reports</div><h4>Pharmaceuticals Industry Mergers and Acquisitions Deals by Top Them... </h4></div> </li><li><div><figure><img src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png" alt="ReportsLogo" original-src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png"/></figure></div><div><div>Reports</div><h4>Future of Pharma - Looking Ahead to 2023 </h4></div> </li></ul> <div>
                    <h5>
                        
                            
                        
                        Data Insights
                    </h5>
                    <p>
                        The gold standard of business intelligence.
                    </p>
                    <p>
                            Find out more
                            
                                
                            
                        
                    </p>
                </div>
                </div></div><section><figure><img src="https://imageproxy.pbkrs.com/https://www.pharmaceutical-technology.com/wp-content/themes/goodlife-wp-B2B/assets/images/GMS-logo.svg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.pharmaceutical-technology.com/wp-content/themes/goodlife-wp-B2B/assets/images/GMS-logo.svg"/></figure><h4> Discover B2B Marketing That Performs </h4><p>
						Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
					</p><p>
							Find out more </p></section></div>



<p>Another feature looks at the boom in activity in China’s pharma space in 2025. </p><div id="slot-one"></div><div id="Sgpollsputhere"></div>



<p>In this issue, we also review the key talking points from this year’s Clinical Data Management Innovation (CDMI) Europe 2025 conference held in Barcelona.</p>



<p>And don’t miss our further news coverage from the recent CPHI conference held in Frankfurt, Germany.</p>



<p><strong>Read the latest issue of Pharma Technology Focus for all this and insights, and analysis from the pharmaceutical industry.</strong></p><div> 
                         <div>


            <div>

                <img src="/wp-content/themes/goodlife-wp-B2B/assets/images/strategic-int.png" alt="" original-src="/wp-content/themes/goodlife-wp-B2B/assets/images/strategic-int.png"/>
            </div>


            <div>

                <span class="gdm-company-profile-unit__form-excerpt">GlobalData Strategic Intelligence</span>
 <div id="gdm-form-wrapper">



                    <h1>
                        US Tariffs are shifting - will you react or anticipate?
                    </h1>
                    <p>Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.</p>
                    <span class="gdm-company-profile-unit__text">By GlobalData</span>
                
          </div>
          </div>  
           </div> Learn more about Strategic Intelligence</div>



<p><strong>You can also subscribe here to receive email notifications when a new issue is available.</strong></p>
<div id="slot-two"></div><div id="slot-three"></div><p></p>



<div>
    
</div>

CPHI

<p>The magazine cover story discusses the rise in M&A deal value in the biopharma sector in 2025 compared to 2024, exploring the factors driving this trend and potential developments in 2026. It highlights increased activity in China's pharma space and reviews key points from the 2025 CDMI Europe conference in Barcelona. The issue also covers insights from the CPHI conference in Frankfurt and offers strategic intelligence on US tariff shifts.</p>

Magazine: Biopharma’s 2025 M&A boom